iBioLaunch Platform successfully expresses hookworm-derived molecule for potential vaccine
Links shared publicly online about this topic.
- 265total visits
iBioLaunch Platform successfully expresses hookworm-derived molecule for potential vaccine
iBio, Inc. today announced that its proprietary iBioLaunch Platform successfully expressed the hookworm-derived molecule known as NaAPR1M-74, which will be evaluated as a potential vaccine candidate for human hookworm disease.
View full resource at news-medical.net
Tags: Vaccination, Worm Parasite, Hookworm, Disease and Condition, Vaccine, disease
Most Recently Shared on May 26, 2011 at 1:43 pm By:
iBioLaunch Platform successfully expresses hookworm-derived molecule for potential vaccine: iBio, Inc. today ann... http://bit.ly/mEbGuA
IBio Announces Successful Production Of Critical Hookworm Vaccine Antigen
medicalnewstoday.com — “iBio, Inc. (NYSE AMEX: IBIO) today announced that its proprietary iBioLaunch™ Platform successfully expressed the hookworm-derived molecule known as NaAPR1M-74, which will be evaluated as a” View full resource at medicalnewstoday.com
Most Recently Shared on May 27, 2011 at 4:05 pm By:
MNT Pharma News Health News and Pharma
IBio Announces Successful Production Of Critical Hookworm Vaccine Antigen http://mnt.to/3Wtg #pharma #pharmaceutical
Advertisement
